ZimVie

ZimVie is a specialized medical device company operating in the dental implantology and spine sectors, though its dental division is the primary focus of the provided data. The company leverages a legacy of innovation from its predecessor, Zimmer Biomet's dental and spine units, to provide integrated solutions including implants, guided surgery, digital planning, and biomaterials. Following its acquisition by the private equity firm ARCHIMED in late 2025, ZimVie operates as a privately held entity, allowing it to focus on strategic growth and product development outside of public market pressures. Its strategy centers on empowering dental professionals through comprehensive product ecosystems and extensive educational programs.

Integrated ecosystem of dental implant systems, digital guided surgery workflows (e.g., RealGUIDE), intraoral scanning partnerships, and biomaterials for site preparation and restoration.

ZimVie competes in a crowded global market dominated by giants like Straumann Group and Envista (Nobel Biocare), and large diversified players like Dentsply Sirona. Competition is based on brand legacy, clinical evidence, product portfolio breadth, digital ecosystem integration, and surgeon training/support.